Catalent Inc at Jefferies London Healthcare Conference Transcript

Nov 21, 2019 / 04:00PM GMT
David Howard Windley - Jefferies LLC, Research Division - MD & Equity Analyst

Okay. Welcome, everybody. Thanks for sticking with us. We've been -- had a busy couple of days. Coming toward the end of day 2 of Jefferies London Healthcare Conference and we're pleased that you are here in support of our conference and hope you're gaining a lot of value from the information that you are collecting. I want to provide you with some more information. I'm Dave Windley. I cover pharma services, pharma outsourcing for Jefferies. A competitor and a leading competitor in that space is Catalent. The company is in the contract manufacturing business. And here to talk with me about Catalent's business and outlook is the company's Chairman and CEO, John Chiminski; and company's SVP and CFO; Wetteny Joseph; Tom Castellano is also in the audience, Treasurer and IR, as well.

Questions and Answers:

David Howard Windley - Jefferies LLC, Research Division - MD & Equity Analyst

So John, I want to start us with kind of a big picture question on the transformation journey
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot